Bart Teeuw

Bart Teeuw is a seasoned Biomedical Lifescience Executive specializing in pharmacovigilance and drug safety, with extensive experience leading teams of over 100 FTE. They held notable positions at prominent companies such as UCB, where they served as Vice President and Head of International Pharmacovigilance, and at Merck Sharp & Dohme as Qualified Person for Pharmacovigilance. Bart earned their PhD and gained valuable experience as a post-doctoral researcher at Utrecht University. Their career also includes leadership roles at Schering-Plough, Genzyme Europe BV, and Astellas Pharma, where they significantly contributed to pharmacovigilance practices and regulatory intelligence.